| Bacteria |
Bacterial DNA-directed RNA polymerase |
IC50 |
20000.0 |
nM |
10.1021/jm00230a002 |
| Bos taurus |
Acetylcholinesterase |
Inhibition |
49.0 |
% |
10.1016/j.ejmech.2011.02.071 |
| Bos taurus |
Cyclooxygenase |
IC50 |
32600.0 |
nM |
10.1016/S0960-894X(01)81022-2 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Candida albicans |
Candida albicans |
Activity |
50.0 |
% |
10.1016/j.bmcl.2021.127815 |
| Canis lupus familiaris |
MDCK |
Papp |
1.23 |
ucm/s |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
Papp |
2.89 |
ucm/s |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
Papp |
3.45 |
ucm/s |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
Papp |
6.7 |
ucm/s |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
permeability |
3.2 |
% |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
permeability |
3.9 |
% |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
permeability |
5.3 |
% |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
permeability |
5.5 |
% |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
permeability |
14.6 |
% |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
permeability |
24.5 |
% |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
permeability |
27.7 |
% |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
permeability |
34.8 |
% |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
permeability |
35.5 |
% |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
permeability |
51.0 |
% |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
permeability |
75.8 |
% |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
permeability |
80.2 |
% |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
Ratio |
1.2 |
None |
10.1016/j.ejmech.2011.04.016 |
| Canis lupus familiaris |
MDCK |
Ratio |
5.1 |
None |
10.1016/j.ejmech.2011.04.016 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cavia porcellus |
Voltage-dependent L-type calcium channel subunit alpha-1C |
IC50 |
5600.0 |
nM |
None |
| Chikungunya virus |
Chikungunya virus |
Activity |
12.5 |
% |
10.1016/j.bmc.2023.117239 |
| Chikungunya virus |
Chikungunya virus |
EC50 |
12000.0 |
nM |
10.1016/j.bmc.2023.117239 |
| Chlorocebus sabaeus |
Vero |
CC50 |
14710.0 |
nM |
10.1101/2020.03.20.999730 |
| Cricetulus griseus |
CHO-AA8 |
IC50 |
1700.0 |
nM |
10.1021/jm00166a015 |
| Cricetulus griseus |
UV4 |
IC50 |
140.0 |
nM |
10.1021/jm00166a015 |
| dengue virus type 2 |
dengue virus type 2 |
EC50 |
5300.0 |
nM |
10.1016/j.ejmech.2019.05.010 |
| Ebolavirus |
Ebolavirus |
IC50 |
1050.0 |
nM |
10.1021/acsmedchemlett.0c00298 |
| Equus caballus |
Cholinesterase |
IC50 |
4500.0 |
nM |
10.1016/j.ejmech.2011.02.071 |
| Fungi |
Cell membrane |
Activity |
21.6 |
mM |
10.1021/acs.jmedchem.0c02056 |
| Fungi |
Cell membrane |
Activity |
37.0 |
mM |
10.1021/acs.jmedchem.0c02056 |
| Fungi |
Cell membrane |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c02056 |
| Gallus gallus |
Riboflavin-binding protein |
Kd |
264.0 |
nM |
10.1021/ml100296z |
| Gallus gallus |
Riboflavin-binding protein |
Ki |
6700.0 |
nM |
10.1021/ml100296z |
| Giardia |
Giardia |
Potency |
129.6 |
nM |
None |
| Giardia |
Giardia |
Potency |
4645.1 |
nM |
None |
| Homo sapiens |
184B5 |
IC50 |
4960.0 |
nM |
10.1016/j.ejmech.2017.05.052 |
| Homo sapiens |
184B5 |
IC50 |
4960.0 |
nM |
10.1016/j.ejmech.2017.11.097 |
| Homo sapiens |
78 kDa glucose-regulated protein |
Potency |
18492.7 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
928.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
2667.0 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Aldehyde oxidase |
IC50 |
3300.0 |
nM |
10.1021/jm100888d |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
1000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
2065.0 |
nM |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
1015.0 |
nM |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
11916.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
2280.0 |
nM |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
855.0 |
nM |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
1825.0 |
nM |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
833.0 |
nM |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
3857.0 |
nM |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
560.0 |
nM |
None |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
Inhibition |
72.0 |
% |
10.1073/pnas.0708036104 |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
1834.9 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
2591.8 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile salt export pump |
IC50 |
101100.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cerebroside-sulfatase |
Potency |
10691.0 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Cyclic GMP-AMP synthase |
IC50 |
7000.0 |
nM |
10.1016/j.ejmech.2022.114480 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA polymerase iota |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
37685.8 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
12312.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
16360.1 |
nM |
None |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
7047.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
1318.0 |
nM |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
448.0 |
nM |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
18422.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
10621.3 |
nM |
None |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
15003.0 |
nM |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glutathione reductase |
IC50 |
1000000.0 |
nM |
10.1016/s0960-894x(01)00528-5 |
| Homo sapiens |
Glutathione reductase |
Inhibition |
nan |
% |
10.1016/j.bmcl.2004.04.088 |
| Homo sapiens |
Heat shock protein HSP 90-alpha |
Activity |
nan |
None |
10.1016/j.bmcl.2006.06.025 |
| Homo sapiens |
HEK293 |
LD50 |
7.6 |
uM |
10.1016/j.bmcl.2006.06.050 |
| Homo sapiens |
HEK293 |
Potency |
20587.8 |
nM |
None |
| Homo sapiens |
HepG2 |
Activity |
57.0 |
% |
10.1021/jm060736s |
| Homo sapiens |
HepG2 |
Activity |
25000000.0 |
RLU/mg |
10.1021/jm060736s |
| Homo sapiens |
HepG2 |
CC50 |
7600.0 |
nM |
10.1039/d0md00057d |
| Homo sapiens |
HepG2 |
CC50 |
9780.0 |
nM |
10.1021/jm401178t |
| Homo sapiens |
HepG2 |
EC50 |
10440.0 |
nM |
10.1021/acs.jmedchem.6b01163 |
| Homo sapiens |
HepG2 |
EC50 |
10440.0 |
nM |
10.1021/acsmedchemlett.7b00202 |
| Homo sapiens |
HepG2 |
EC50 |
7653700.0 |
nM |
10.1021/acsmedchemlett.8b00498 |
| Homo sapiens |
HepG2 |
EC90 |
18.23 |
uM |
10.1021/acs.jmedchem.6b01163 |
| Homo sapiens |
HepG2 |
LD50 |
7.9 |
uM |
10.1016/j.bmcl.2006.06.050 |
| Homo sapiens |
HERG |
AC50 |
700.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
3535.0 |
nM |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
3476.0 |
nM |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
692.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-11.0 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
12.85 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
8436.8 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
HT-1080 |
IC50 |
29000.0 |
nM |
10.1016/j.bmc.2022.117043 |
| Homo sapiens |
HT-29 |
IC50 |
55000.0 |
nM |
10.1021/jm00027a008 |
| Homo sapiens |
Huh-7 |
CC50 |
19610.0 |
nM |
10.1073/pnas.0802982105 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
MCF7 |
Activity |
nan |
None |
10.1016/j.ejmech.2017.11.097 |
| Homo sapiens |
MCF7 |
IC50 |
4190.0 |
nM |
10.1016/j.ejmech.2017.05.052 |
| Homo sapiens |
MCF7 |
IC50 |
4190.0 |
nM |
10.1016/j.ejmech.2017.11.097 |
| Homo sapiens |
MCF7 |
IC50 |
7500.0 |
nM |
10.1016/j.ejmech.2019.01.028 |
| Homo sapiens |
MCF7-DOX |
MDR ratio |
1.3 |
None |
10.1021/jm970786k |
| Homo sapiens |
MDA-MB-231 |
IC50 |
3250.0 |
nM |
10.1016/j.ejmech.2017.05.052 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
3250.0 |
nM |
10.1016/j.ejmech.2017.11.097 |
| Homo sapiens |
MDA-MB-468 |
IC50 |
3960.0 |
nM |
10.1016/j.ejmech.2017.05.052 |
| Homo sapiens |
MDA-MB-468 |
IC50 |
3960.0 |
nM |
10.1016/j.ejmech.2017.11.097 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
23778.1 |
nM |
None |
| Homo sapiens |
Mu opioid receptor |
AC50 |
5861.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
1489.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
359.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
767.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
964.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
343.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
1255.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
266.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
1983.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
277.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
3736.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
2684.0 |
nM |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Niemann-Pick C1 protein |
Potency |
58047.9 |
nM |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
6924.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
2896.0 |
nM |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
2872.0 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
16360.1 |
nM |
None |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
Potency |
26854.5 |
nM |
None |
| Homo sapiens |
P-glycoprotein 1 |
EC50 |
14400.0 |
nM |
10.1097/00001813-199607000-00012 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Phospholipase A2 group 1B |
Inhibition |
14.9 |
% |
10.1021/jm00111a048 |
| Homo sapiens |
Phospholipase A2 group IIA |
IC50 |
76000000.0 |
nM |
10.1021/jm960437a |
| Homo sapiens |
Phospholipase A2 group IIA |
Inhibition |
48.9 |
% |
10.1021/jm00014a032 |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Prion protein |
EC50 |
300.0 |
nM |
10.1021/jm034093h |
| Homo sapiens |
Prion protein |
RUmax |
87.3 |
% |
10.1016/j.ejmech.2011.04.016 |
| Homo sapiens |
Progesterone receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
46109.1 |
nM |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
21192.3 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
14689.2 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
16481.6 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
18492.7 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
26121.6 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
2261.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
2663.0 |
nM |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
761.0 |
nM |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Serum albumin |
Ka |
7.0 |
10^3/M |
10.1016/j.bmc.2008.01.053 |
| Homo sapiens |
SH-SY5Y |
IC50 |
8570.0 |
nM |
10.1016/j.bmc.2022.117043 |
| Homo sapiens |
SH-SY5Y |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
SK-N-AS |
IC50 |
nan |
None |
10.1016/j.bmc.2022.117043 |
| Homo sapiens |
Sodium channel alpha subunits; brain (Types I, II, III) |
IC50 |
3300.0 |
nM |
10.1021/jm00381a019 |
| Homo sapiens |
Sodium channel alpha subunits; brain (Types I, II, III) |
Inhibition |
73.3 |
% |
10.1021/jm00381a019 |
| Homo sapiens |
Telomerase reverse transcriptase |
Inhibition |
50.0 |
% |
10.1016/j.bmcl.2004.04.055 |
| Homo sapiens |
Telomerase reverse transcriptase |
Inhibition |
82.0 |
% |
10.1016/j.bmcl.2004.04.055 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
1000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Tumor susceptibility gene 101 protein |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
4466.8 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
U-251 |
IC50 |
5000.0 |
nM |
10.1016/j.ejmech.2018.12.033 |
| Homo sapiens |
U2OS |
EC |
0.2 |
uM |
10.1021/acs.jmedchem.7b01019 |
| Homo sapiens |
U2OS |
EC50 |
250.0 |
nM |
10.1016/j.ejmech.2022.114846 |
| Homo sapiens |
U2OS |
IC50 |
2500.0 |
nM |
10.1016/j.ejmech.2022.114846 |
| Homo sapiens |
U2OS |
LD50 |
2.5 |
uM |
10.1021/acs.jmedchem.7b01019 |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
20969.6 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 2 |
Potency |
14689.2 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
WIL2-NS |
CC50 |
4800.0 |
nM |
10.1039/d0md00057d |
| Leishmania infantum |
Trypanothione reductase |
IC50 |
13530.0 |
nM |
10.1016/j.ejmech.2021.113915 |
| Leishmania major |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase |
Potency |
5358.2 |
nM |
None |
| Mesocricetus auratus |
BHK-21 |
CC50 |
18590.0 |
nM |
10.1021/acs.jmedchem.9b00775 |
| Mesocricetus auratus |
BHK-21 |
CC50 |
19800.0 |
nM |
10.1016/j.bmc.2023.117239 |
| Mus musculus |
Frizzled-8 |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b02020 |
| Mus musculus |
HT-22 |
Activity |
nan |
None |
10.1016/j.bmcl.2014.02.006 |
| Mus musculus |
HT-22 |
EC50 |
9090.0 |
nM |
10.1016/j.bmcl.2014.02.006 |
| Mus musculus |
Indoleamine 2,3-dioxygenase 2 |
Inhibition |
55.0 |
% |
10.1016/j.bmcl.2012.10.010 |
| Mus musculus |
Mast cell |
Inhibition |
8.7 |
% |
10.1021/np010016i |
| Mus musculus |
Mast cell |
Inhibition |
18.4 |
% |
10.1021/np010016i |
| Mus musculus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Mus musculus |
ED50 |
100.0 |
ug ear-1 |
10.1016/S0960-894X(01)81022-2 |
| Mus musculus |
Mus musculus |
ED50 |
nan |
None |
10.1016/S0960-894X(01)81022-2 |
| Mus musculus |
N2a |
MTD |
2.5 |
uM |
10.1016/j.ejmech.2011.04.016 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Prion protein |
IC50 |
95.1 |
nM |
10.1021/acs.jmedchem.2c00205 |
| Mus musculus |
ScN2a |
Activity |
2.5 |
uM |
10.1016/j.bmc.2008.05.060 |
| Mus musculus |
ScN2a |
Activity |
500.0 |
nM |
10.1021/jm060773j |
| Mus musculus |
ScN2a |
EC50 |
300.0 |
nM |
10.1021/jm060773j |
| Mus musculus |
ScN2a |
EC50 |
500.0 |
nM |
10.1016/j.bmcl.2006.06.050 |
| Mus musculus |
ScN2a |
EC50 |
800.0 |
nM |
10.1021/jm061045z |
| Mus musculus |
ScN2a |
LD50 |
7.8 |
uM |
10.1021/jm061045z |
| Mus musculus |
ScN2a |
LD50 |
9.6 |
uM |
10.1016/j.bmcl.2006.06.050 |
| Mus musculus |
Transient receptor potential cation channel subfamily M member 7 |
Inhibition |
nan |
% |
None |
| Naja naja |
Phospholipase A2, acidic |
IC50 |
2150000.0 |
nM |
10.1021/np970221r |
| Naja naja |
Phospholipase A2, acidic |
IC50 |
2160000.0 |
nM |
10.1021/np9604339 |
| Naja naja |
Phospholipase A2, acidic |
Inhibition |
85.5 |
% |
10.1021/np9604339 |
| Oryctolagus cuniculus |
Aldehyde oxidase |
IC50 |
10000.0 |
nM |
10.1021/jm100888d |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Ovis aries |
Prostaglandin G/H synthase (cyclooxygenase) |
IC50 |
130000.0 |
nM |
10.1016/S0960-894X(01)81260-9 |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
80.0 |
% |
10.1021/jm00140a022 |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
92.0 |
% |
10.1021/jm00140a022 |
| Plasmodium falciparum |
Histidine-rich protein |
IC50 |
292000.0 |
nM |
10.1128/aac.00985-06 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
5.0 |
nM |
10.1016/j.bmcl.2004.12.037 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
8.0 |
nM |
10.1016/j.bmcl.2004.12.037 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
8.13 |
nM |
10.1073/pnas.0802982105 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
11.0 |
nM |
10.1128/aac.01418-06 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
14.22 |
nM |
10.1073/pnas.0802982105 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
32.0 |
nM |
10.1016/j.bmcl.2004.12.037 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
33.0 |
nM |
10.1128/aac.01418-06 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
13.0 |
nM |
10.1007/s00044-007-9025-8 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
18.0 |
nM |
10.1021/acs.jmedchem.8b01961 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
23.0 |
nM |
10.1021/acs.jmedchem.8b01961 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
29.0 |
nM |
10.1021/acs.jmedchem.8b01961 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
43.0 |
nM |
10.1007/s00044-007-9025-8 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
43.0 |
nM |
10.1016/j.ejmech.2008.02.005 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
41000.0 |
nM |
10.1016/j.bmc.2010.01.068 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
None |
10.1021/acs.jmedchem.8b01961 |
| Plasmodium yoelii |
Plasmodium yoelii |
Activity |
nan |
None |
10.1126/science.1211936 |
| Plasmodium yoelii |
Plasmodium yoelii |
IC50 |
165.7 |
nM |
10.1126/science.1211936 |
| Plasmodium yoelii |
Plasmodium yoelii |
Schizont size |
26.3 |
um |
10.1126/science.1211936 |
| Plasmodium yoelii yoelii |
Plasmodium yoelii yoelii |
IC50 |
30000.0 |
nM |
10.1128/aac.01043-07 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
3414.0 |
nM |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
1890.0 |
nM |
None |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Arachidonate 5-lipoxygenase |
IC50 |
130000.0 |
nM |
10.1016/S0960-894X(01)81022-2 |
| Rattus norvegicus |
Arachidonate 5-lipoxygenase |
IC50 |
130000.0 |
nM |
10.1016/S0960-894X(01)81260-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Phospholipase A2 group 1B |
IC50 |
100000.0 |
nM |
10.1016/S0960-894X(01)81260-9 |
| Rattus norvegicus |
Phospholipase A2 group IIA |
IC50 |
320000000.0 |
nM |
10.1021/jm960437a |
| Rattus norvegicus |
Rattus norvegicus |
ED30 |
5.8 |
uM kg-1 |
10.1016/S0960-894X(01)81260-9 |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
28800.0 |
nM |
10.1021/jm020102v |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
31200.0 |
nM |
10.1021/jm020102v |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition rate |
37.4 |
% |
10.1021/jm00111a048 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier family 22 member 2 |
Activity |
nan |
None |
10.1152/ajprenal.1999.277.6.f890 |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
631.0 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
12589.3 |
nM |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
IC50 |
5200.0 |
nM |
10.1002/jat.2784 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c02056 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.0c02056 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
MIC |
2500.0 |
nM |
10.1021/acs.jmedchem.0c02056 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
MIC |
83000.0 |
nM |
10.1021/acs.jmedchem.0c02056 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
MIC |
50000000.0 |
nM |
10.1021/acs.jmedchem.0c02056 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Ratio |
1.53 |
None |
10.1021/acs.jmedchem.0c02056 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Ratio |
1.69 |
None |
10.1021/acs.jmedchem.0c02056 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Ratio |
30.0 |
None |
10.1021/acs.jmedchem.0c02056 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Ratio |
600.0 |
None |
10.1021/acs.jmedchem.0c02056 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-4.1 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
-0.004903 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
50000.0 |
nM |
10.1101/2020.03.20.999730 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.24 |
% |
10.6019/CHEMBL4495565 |
| Sus scrofa |
Phospholipase A2 group 1B |
IC50 |
100000.0 |
nM |
10.1016/S0960-894X(01)81022-2 |
| Trypanosoma cruzi |
Trypanothione reductase |
IC50 |
133000.0 |
nM |
10.1016/s0960-894x(01)00528-5 |
| Trypanosoma cruzi |
Trypanothione reductase |
Inhibition |
nan |
% |
10.1016/j.bmcl.2004.04.088 |
| Trypanosoma cruzi |
Trypanothione reductase |
Inhibition constant |
3.22 |
None |
10.1021/jm9603781 |
| Trypanosoma cruzi |
Trypanothione reductase |
Ki |
19000.0 |
nM |
10.1016/j.bmcl.2009.04.060 |
| Trypanosoma cruzi |
Trypanothione reductase |
Ki |
19000.0 |
nM |
10.1016/j.ejmech.2017.08.014 |
| Trypanosoma cruzi |
Trypanothione reductase |
Ki |
19000.0 |
nM |
10.1021/jm990386s |
| Zika virus |
Zika virus |
EC50 |
2270.0 |
nM |
10.1021/acs.jmedchem.9b00775 |
| None |
ADMET |
Activity |
100.0 |
% |
10.1021/ml3003605 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/jm201082a |
| None |
ADMET |
Biotransformation |
nan |
None |
10.1038/s41586-019-1291-3 |
| None |
ADMET |
CC50 |
3920.0 |
nM |
10.1021/jm401178t |
| None |
ADMET |
CL |
5.1 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
eLog D |
1.1 |
None |
10.1021/jm0200409 |
| None |
ADMET |
Fraction ionised |
1.664 |
None |
10.1021/jm0200409 |
| None |
ADMET |
Fu |
0.0002 |
None |
10.1021/jm0200409 |
| None |
ADMET |
Fu |
0.103 |
None |
10.1021/jm0200409 |
| None |
ADMET |
Fu |
0.103 |
None |
10.1021/jm030408h |
| None |
ADMET |
Log k' |
-0.064 |
None |
10.1021/jm00135a006 |
| None |
ADMET |
Log k' |
0.329 |
None |
10.1021/jm00135a006 |
| None |
ADMET |
Log k' |
0.344 |
None |
10.1021/jm00135a006 |
| None |
ADMET |
Log k' |
0.48 |
None |
10.1021/jm00135a006 |
| None |
ADMET |
Log k' |
0.574 |
None |
10.1021/jm00135a006 |
| None |
ADMET |
Log k' |
0.721 |
None |
10.1021/jm00135a006 |
| None |
ADMET |
Log k' |
0.761 |
None |
10.1021/jm00135a006 |
| None |
ADMET |
Log k' |
0.807 |
None |
10.1021/jm00135a006 |
| None |
ADMET |
Log k' |
0.888 |
None |
10.1021/jm00135a006 |
| None |
ADMET |
Log k' |
0.889 |
None |
10.1021/jm00135a006 |
| None |
ADMET |
log Pe |
-6.6 |
None |
10.1021/jm061045z |
| None |
ADMET |
MRT |
150.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Peff |
19.3 |
ucm/s |
10.1016/j.ejmech.2011.04.016 |
| None |
ADMET |
PPB |
88.59 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Ratio CC50/EC50 |
1.6 |
None |
10.1016/j.bmc.2023.117239 |
| None |
ADMET |
Ratio LD50/EC50 |
18.5 |
None |
10.1016/j.bmcl.2006.06.050 |
| None |
ADMET |
Selectivity index |
0.29 |
None |
10.1101/2020.03.20.999730 |
| None |
ADMET |
T1/2 |
120.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
45.0 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
124.0 |
L.kg-1 |
10.1021/jm030408h |
| None |
ADMET |
Vdss |
223.0 |
L.kg-1 |
10.1021/jm0200409 |
| None |
Heme |
Activity |
nan |
None |
10.1038/nchembio806 |
| None |
Heme |
IC50 |
41000.0 |
nM |
10.1007/s00044-007-9025-8 |
| None |
Heme |
Inhibition |
nan |
% |
10.1038/nchembio806 |
| None |
Hepatocyte |
TC50 |
1.16 |
10'4nM |
10.1128/aac.01043-07 |
| None |
Hepatotoxicity |
DILI positive/negative |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Mast cell |
IC50 |
13700.0 |
nM |
10.1021/np049811x |
| None |
Mast cell |
IC50 |
23300.0 |
nM |
10.1021/np049811x |
| None |
NON-PROTEIN TARGET |
Activity |
0.8 |
uM |
10.1016/j.bmc.2008.05.060 |
| None |
NON-PROTEIN TARGET |
Activity |
0.8 |
uM |
10.1016/j.ejmech.2011.04.016 |
| None |
NON-PROTEIN TARGET |
Activity |
2.0 |
uM |
10.1016/j.bmc.2008.05.060 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1016/j.bmcl.2014.02.006 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1016/j.ejmech.2011.04.016 |
| None |
NON-PROTEIN TARGET |
EC50 |
230.0 |
nM |
10.1016/j.bmc.2008.05.060 |
| None |
NON-PROTEIN TARGET |
EC50 |
230.0 |
nM |
10.1016/j.ejmech.2011.04.016 |
| None |
NON-PROTEIN TARGET |
EC50 |
300.0 |
nM |
10.1021/jm900920x |
| None |
NON-PROTEIN TARGET |
EC50 |
400.0 |
nM |
10.1021/ml3003605 |
| None |
NON-PROTEIN TARGET |
EC50 |
420.0 |
nM |
10.1021/jm900920x |
| None |
NON-PROTEIN TARGET |
EC50 |
460.0 |
nM |
10.1016/j.bmc.2008.05.060 |
| None |
NON-PROTEIN TARGET |
EC50 |
590.0 |
nM |
10.1016/j.bmc.2008.05.060 |
| None |
NON-PROTEIN TARGET |
EC50 |
590.0 |
nM |
10.1016/j.ejmech.2011.04.016 |
| None |
NON-PROTEIN TARGET |
EC50 |
936.0 |
nM |
10.1038/nchembio873 |
| None |
NON-PROTEIN TARGET |
EC50 |
1880.0 |
nM |
10.1016/j.bmc.2008.05.060 |
| None |
NON-PROTEIN TARGET |
EC50 |
1880.0 |
nM |
10.1016/j.ejmech.2011.04.016 |
| None |
NON-PROTEIN TARGET |
EC50 |
2120.0 |
nM |
10.1016/j.ejmech.2016.10.024 |
| None |
NON-PROTEIN TARGET |
EC50 |
11900.0 |
nM |
10.1016/j.ejmech.2016.10.024 |
| None |
NON-PROTEIN TARGET |
EC50 |
nan |
None |
10.1038/nchembio873 |
| None |
NON-PROTEIN TARGET |
Fu |
0.13 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.1 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
1100.0 |
nM |
10.1016/j.bmcl.2010.12.132 |
| None |
NON-PROTEIN TARGET |
Selectivity Index |
11.0 |
None |
10.1016/j.bmc.2008.05.060 |
| None |
No relevant target |
LogD |
1.911 |
None |
10.1021/jm00135a006 |
| None |
No relevant target |
LogD |
1.966 |
None |
10.1021/jm00135a006 |
| None |
No relevant target |
LogD |
1.986 |
None |
10.1021/jm00135a006 |
| None |
No relevant target |
LogD |
2.219 |
None |
10.1021/jm00135a006 |
| None |
No relevant target |
LogD7.4 |
2.17 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
pKa |
7.73 |
None |
10.1021/jm030408h |
| None |
No relevant target |
pKa |
10.2 |
None |
10.1021/jm0200409 |
| None |
No relevant target |
pKa |
10.2 |
None |
10.1021/jm030408h |
| None |
No relevant target |
pKa |
10.2 |
None |
10.1021/jm070524a |
| None |
No relevant target |
Solubility |
400000.0 |
nM |
10.1021/jm061045z |
| None |
Nucleic Acid |
Inhibition |
nan |
% |
10.1016/j.bmcl.2011.12.103 |
| None |
Nucleic Acid |
Log Kd |
4.25 |
None |
10.1021/jm00370a007 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1021/ci6004542 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1021/mp100103e |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
CC50 |
2.34 |
nM |
10.1021/acsmedchemlett.7b00230 |
| None |
Unchecked |
EC50 |
4230.0 |
nM |
10.1021/acs.jmedchem.6b01163 |
| None |
Unchecked |
EC50 |
4230.0 |
nM |
10.1021/acsmedchemlett.7b00202 |
| None |
Unchecked |
EC50 |
2974100.0 |
nM |
10.1021/acsmedchemlett.8b00498 |
| None |
Unchecked |
EC90 |
9.94 |
uM |
10.1021/acs.jmedchem.6b01163 |
| None |
Unchecked |
Hepatotoxicity (acute) |
4.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
739.0 |
nM |
None |
| None |
Unchecked |
IC50 |
1076.0 |
nM |
None |
| None |
Unchecked |
IC50 |
1275.0 |
nM |
None |
| None |
Unchecked |
IC50 |
1521.0 |
nM |
None |
| None |
Unchecked |
IC50 |
16990.0 |
nM |
10.1016/j.bmcl.2020.127371 |
| None |
Unchecked |
IC50 |
19000.0 |
nM |
10.1016/j.bmcl.2021.128289 |
| None |
Unchecked |
IC50 |
73000.0 |
nM |
10.1016/j.bmcl.2004.05.031 |
| None |
Unchecked |
IC50 |
370000.0 |
nM |
10.1021/acs.jmedchem.0c02056 |
| None |
Unchecked |
IC50 |
1000000.0 |
nM |
10.1021/acs.jmedchem.0c02056 |
| None |
Unchecked |
IC50 |
1600000.0 |
nM |
10.1021/acs.jmedchem.0c02056 |
| None |
Unchecked |
IC50 |
3490000.0 |
nM |
10.1021/acs.jmedchem.0c02056 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
IFI |
6.952 |
% |
10.1073/pnas.0802982105 |
| None |
Unchecked |
Inhibition |
75.0 |
% |
10.1016/j.bmcl.2004.04.055 |
| None |
Unchecked |
Inhibition |
80.0 |
% |
10.1016/j.bmcl.2004.04.055 |
| None |
Unchecked |
Inhibition |
93.0 |
% |
10.1016/j.bmcl.2004.04.055 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.0c02056 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.8b01961 |
| None |
Unchecked |
Kd |
7550.0 |
nM |
10.1021/acsmedchemlett.0c00298 |
| None |
Unchecked |
Ki |
719.0 |
nM |
None |
| None |
Unchecked |
Ki |
956.0 |
nM |
None |
| None |
Unchecked |
Ki |
1014.0 |
nM |
None |
| None |
Unchecked |
Ki |
1163.0 |
nM |
None |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Km |
750000.0 |
nM |
10.1021/acs.jmedchem.0c02056 |
| None |
Unchecked |
Km |
770000.0 |
nM |
10.1021/acs.jmedchem.0c02056 |
| None |
Unchecked |
Potency |
1000.0 |
nM |
None |
| None |
Unchecked |
Potency |
6510.4 |
nM |
None |
| None |
Unchecked |
Potency |
6513.1 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
28183.8 |
nM |
None |
| None |
Unchecked |
Ratio |
11.5 |
None |
10.1021/jm00166a015 |
| None |
Unchecked |
Selectivity |
7.5 |
None |
10.1016/s0960-894x(01)00528-5 |
| None |
Unchecked |
Selectivity Index |
0.38 |
None |
10.1128/aac.01043-07 |
| None |
Unchecked |
Vmax |
113.0 |
nmol/min |
10.1021/acs.jmedchem.0c02056 |
| None |
Unchecked |
Vmax |
158.0 |
nmol/min |
10.1021/acs.jmedchem.0c02056 |